Mark Cuban ‘Very Involved’, Insists Generics Company CEO
As He Admits COVID-19 Accelerated Company Timeline
Executive Summary
Announcing his “first step to take on pricing of generic drugs,” billionaire Mark Cuban recently associated his name with a new US generics company “to show that capitalism can be compassionate.” In an exclusive chat with Generics Bulletin, the newly established company’s CEO Alex Oshmyansky revealed that they started working on the company “in stealth” since 2018.
You may also be interested in...
Mark Cuban’s Generics Company Launches Online Pharmacy
Mark Cuban’s generics venture has launched its online pharmacy in the US, highlighting in particular three products – imatinib, mesalamine and colchicine – that it says “epitomize the pharmacy’s striking savings.”
Generics Industry At The Forefront In War Against COVID-19 In 2021
As the COVID-19 pandemic continued in 2021, the off-patent industry stepped in to provide relief in a variety of ways, whether through securing supplies of essential medicines or helping to manufacture and distribute newly-developed treatments.
Data-Sharing Key To US Supply Chain Resilience And Keeping Drug Costs Under Control
Aside from a few high-profile exceptions, the biopharma industry supply chain has remained secure and resilient during the COVID-19 pandemic, outperforming retail and consumer goods. Chip Davis, Jr., head of the Healthcare Distribution Alliance, spoke with In Vivo about the need for a long-term industrial policy for drug manufacturing, real-time data-sharing and transparency in the supply chain, and minimizing disruptions.